Le marché des dispositifs d'autotransfusion devrait passer de 1 000,26 millions de dollars US en 2021 à 1 331,99 millions de dollars US d'ici 2028 ; on estime qu'il augmentera à un TCAC de 4,2 % de 2021 à 2028.
La transplantation d'organes est une intervention chirurgicale réalisée en cas de défaillance d'un organe. Habituellement, la transplantation d'organes est effectuée pour des organes tels que le cur, le foie et les reins ; cependant, avec l'augmentation des cas de maladies chroniques, la transplantation est nécessaire pour d'autres organes tels que les poumons, le pancréas, la cornée et les tissus vasculaires. Ces procédures prennent généralement des heures, et il y a beaucoup de pertes de sang, et l'autotransfusion est l'une des méthodes précieuses pour prévenir les pertes de sang. Selon le United Network for Organ Sharing (UNOS), les greffes d'organes effectuées aux États-Unis n'ont cessé d'augmenter, avec plus de 41 000 greffes réalisées en 2021. De même, selon les données du World Transplant Registry, l'Espagne représentait 20 % de tous les dons d'organes dans le monde. UE en 2019 et 6% des dons mondiaux. Le taux de donneurs d'organes en Australie s'est amélioré ces dernières années, passant à 21,8 donneurs par million d'habitants en 2019.
Aperçus stratégiques
De même, le Canada compte 22,2 donneurs par million d'habitants et s'améliore régulièrement, attribuée en partie à la figure des "médecins du don" - médecins de soins intensifs responsables du don d'organes. Selon le Registre mondial des greffes, la Chine comptait 5 818 donneurs en 2019, soit 4,1 par million d'habitants et l'Inde avait 715 donneurs ou 0,5 par million d'habitants en 2019. En revanche, la Russie avait un taux légèrement plus élevé de 5,1 donneurs par million d'habitants. Le partenariat public-privé en collaboration avec les coordinateurs de transplantation a apporté une contribution significative à l'amélioration de la transplantation d'organes. Les pays en développement et les pays développés ont connu une augmentation des chirurgies de transplantation d'organes. Par exemple, des pays en développement tels que l'Inde et Singapour sont en train de devenir des destinations de tourisme médical en Asie-Pacifique. Les pays progressent en termes de fourniture de traitements médicaux meilleurs et avancés. Ainsi, le besoin croissant de transplantation d'organes est l'un des principaux facteurs à l'origine de la demande de diagnostics de transplantation tels que les dispositifs d'autotransfusion.
Le processus d'autotransfusion implique la réinjection du sang du patient. Le sang est prélevé dans la cavité péritonéale ou la région du thorax. Le processus peut être effectué avant la chirurgie ou pendant et après la chirurgie en utilisant le système d'autotransfusion. Les procédures médicales, telles que les remplacements articulaires, les chirurgies de la colonne vertébrale et cardiaques, entre autres, nécessitent une autotransfusion. Il aide à réduire le risque d'infection et élimine également les problèmes et les complications associés à la mise en banque et à l'administration de sang de donneur homologue. Il aide à prévenir la transmission des maladies à diffusion hématogène liées à la transfusion chez les patients.
Aperçu du marché Développements technologiques dans les dispositifs d'autotransfusion
Les dispositifs d'autotransfusion sont généralement déployés lors d'interventions chirurgicales de longue durée, telles que la transplantation rénale, et en cas d'urgence. Ces chirurgies sont associées à des risques de perte de sang excessive, ce qui rend difficile la compensation de la perte de sang avec du sang neuf, en particulier en cas de groupes sanguins rares. En raison de la forte demande, les principaux acteurs du marché des dispositifs d'autotransfusion proposent des dispositifs d'autotransfusion avancés et entièrement automatisés qui réduisent les interventions humaines. Par exemple, en avril 2021, le B-Capta de LivaNova PLC a été approuvé par la Food and Drug Administration des États-Unis. Pendant les chirurgies complexes de pontage cardio-pulmonaire pédiatrique et adulte, cet appareil aide à la surveillance rapide et précise des paramètres veineux et des gaz sanguins. De même, en avril 2019, BD a lancé ses milieux de contrôle qualité BD BACTEC dans le monde entier pour aider à identifier les unités de plaquettes contaminées lors des transfusions.
De plus, de nombreuses entreprises ont utilisé des activités stratégiques telles que des acquisitions, des partenariats et autres pour conquérir le marché. Par exemple, Medtronics a acquis AV Medical Technologies en octobre 2019. En décembre 2019, Getinge a acheté Applikon Biotechnology, un leader mondial dans le développement et la fourniture de systèmes de bioréacteurs innovants, du laboratoire à l'échelle industrielle. Ainsi, de telles avancées sont susceptibles d'apporter de nouvelles tendances sur le marché des dispositifs d'autotransfusion dans les années à venir.
Application-Based Insights
Sur la base des applications, le marché des dispositifs d'autotransfusion est segmenté en chirurgies cardiaques, chirurgies orthopédiques, transplantation d'organes, procédures de traumatologie et autres. Le segment des chirurgies cardiaques détenait la plus grande part du marché en 2021, tandis que le segment de la transplantation d'organes devrait également enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.
Dispositifs d'autotransfusion Marché, par application - en 2021-2028
Les acteurs du marché des dispositifs d'autotransfusion adoptent des stratégies organiques telles que le lancement et l'expansion de produits pour étendre leur empreinte et leur portefeuille de produits à l'échelle mondiale et répondre à la demande croissante. Les développements des entreprises sur le marché des dispositifs d'autotransfusion ont été caractérisés comme des développements organiques et inorganiques. Diverses entreprises se concentrent sur des stratégies organiques, telles que le lancement et l'expansion de produits. Les stratégies de croissance inorganiques observées sur le marché des dispositifs d'autotransfusion étaient les partenariats et les collaborations. Ces stratégies de croissance ont aidé les acteurs du marché des dispositifs d'autotransfusion dans l'expansion de leurs activités et renforcé leur présence géographique. De plus, des stratégies de croissance telles que des acquisitions et des partenariats ont contribué à renforcer leur clientèle et à élargir leur portefeuille de produits. Les sociétés ont maximisé leur croissance avec plusieurs stratégies inorganiques pour améliorer la valeur marchande des dispositifs d'autotransfusion et leur position sur le marché des dispositifs d'autotransfusion. Les développements organiques représentent 66,67 % du total des développements stratégiques sur le marché des dispositifs d'autotransfusion. Alors que les stratégies inorganiques représentent 33,33 % de la croissance des entreprises.
Le marché des dispositifs d'autotransfusion a été segmenté comme suit :
Le marché des dispositifs d'autotransfusion est segmenté en fonction du type, de l'application et de l'utilisateur final. En fonction du type, le marché des dispositifs d'autotransfusion est divisé en produits et accessoires. Le marché des dispositifs d'autotransfusion, basé sur l'application, est segmenté en chirurgies cardiaques, chirurgies orthopédiques, transplantation d'organes, procédures de traumatologie et autres.
Le marché des dispositifs d'autotransfusion, basé sur l'utilisateur final, est divisé en hôpitaux, cliniques spécialisées et centres de chirurgie ambulatoire.
Profils des entreprises sur le marché des dispositifs d'autotransfusion
- BD
- Braile Biomedica
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Medtronic
- Redax SpA
- SARSTEDT AG and Co. KG
- Teleflex Incorporated
- Zimmer Biomet
< li>LivaNova PLC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The accessories segment dominated the global autotransfusion devices market and held the largest revenue share of 55.66% in 2021.
The intraoperative autotransfusion systems segment dominated the global autotransfusion devices market and held the largest revenue share of 71.70% in 2021
Key factors that are driving the growth of this market are rapid increase in chronic diseases, rise in transplant, and difficulty in obtaining blood of rare groups.
The autotransfusion process involves the reinfusion of the patient's blood collected from the peritoneal cavity or thorax region. The process can be accomplished before surgery or during and after the surgery using the autotransfusion system. Medical procedures, such as joint replacement, spinal surgeries, and cardiac surgery require autotransfusion. It helps reduce the risk of infection, and abolishes the problems and complications associated with the banking and administration of homologous donor blood. It also prevents transmission of transfusion-related blood-borne diseases in patients.
The organ transplantation segment dominated the global autotransfusion devices market and held the largest revenue share of 3.22% in 2021.
The ambulatory surgery centers segment dominated the global autotransfusion devices market and accounted for the largest revenue share of 30.12% in 2021.
The autotransfusion devices market majorly consists of the players such as Medtronic; Fresenius SE & Co. KGaA; Teleflex Incorporated; BD; Zimmer Biomet; Braile Biomedica; Haemonetics Corporation; SARSTEDT AG and Co. KG; LivaNova PLC; Redax S.p.A. among others.
Global autotransfusion devices market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for autotransfusion devices. The US is estimated to hold the largest share in the autotransfusion devices market during the forecast period. The growth of the market is attributed to factors such as increasing prevalence of cancer in the US, and cancer awareness initiatives undertaken by local governments and global health organizations. In addition, growth involvement of rare blood groups, rising number of transplant procedures and rising prevalence of chronic diseases in the region stimulate the growth of autotransfusion devices market in North America. On the other hand, need for reinfusion of blood, and advancements in healthcare facilities and infrastructure in the Asia Pacific are expected to account for the fastest growth of the region during the coming years.
The List of Companies - Autotransfusion Devices Market
- Medtronic
- Fresenius SE & Co. KGaA
- Teleflex Incorporated
- BD
- Zimmer Biomet
- Braile Biomedica
- Haemonetics Corporation
- SARSTEDT AG and Co. KG
- LivaNova PLC
- Redax S.p.A.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Mar 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2022
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)